Lupus care under the microscope: new registry tracks Real-World treatment in kazakhstan
NCT ID NCT06899633
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is a registry that will follow about 500 adults with lupus (SLE) in Kazakhstan to see how the disease behaves and how doctors treat it in everyday practice. Researchers will look at disease activity, organ damage, and which medications are used. No new treatments are being tested—the goal is simply to collect information to better understand lupus care in this region.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this registry could reveal how lupus is actually managed in Kazakhstan, pointing to gaps in care and opportunities to improve treatment guidelines.
What could go wrong
This is an observational study, not a treatment trial. It collects data only and cannot directly improve patient outcomes. Results may not apply outside Kazakhstan.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ESEM Pharmacy LLP
Almaty, Kazakhstan
-
JSC Research Institute of Cardiology and Internal Diseases
Almaty, Kazakhstan
-
Medical Center for Joint Diseases of Shymkent LLP
Shymkent, Kazakhstan
-
Municipal State Enterprise on the Right of Economic Management - Pavlodar Regional Hospital named after G. Sultanov
Pavlodar, Kazakhstan
-
Municipal state enterprise with the right of economic management City polyclinic No. 5
Almaty, Kazakhstan
-
Non-Profit Joint Stock Company Kazakh National Medical University named after S.D. Asfendiyarov
Almaty, Kazakhstan
-
Non-Profit Joint Stock Company Semey Medical University - University Hospital
Semey, Kazakhstan
-
Republican Diagnostic Center of Astana Corporate Fund University Medical Center
Astana, Kazakhstan
-
State Enterprise on the Right of Economic Management - Aktobe Medical Center
Aktobe, Kazakhstan
-
State Enterprise on the Right of Economic Management - Regional Clinical Hospital of the Turkestan Region
Shymkent, Kazakhstan
-
State-owned enterprise on the right of economic management -Taldykorgan City Polyclinic
Taldykorgan, Kazakhstan
-
Zhambyl Regional Multidisciplinary Hospital of the Health Department of the Akimat of Zhambyl Region
Taraz, -- Select --, Kazakhstan